Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
ScanBrit Dietary Intervention in Autism
This study is ongoing, but not recruiting participants.
Sponsors and Collaborators: Center for Autisme, Denmark
Norway: Bo Nils og Seim Family Settlement
The Robert Luff Foundation, United Kingdom
Eric Birger Christensen Fond, Denmark
Norsk Proteinintolerance, Norway
Information provided by: Center for Autisme, Denmark
ClinicalTrials.gov Identifier: NCT00614198
  Purpose

A growing body of research indicates that intervention, excluding foods containing the proteins, gluten and casein, from the diet of children diagnosed with an autism spectrum disorder may have a positive effect on behaviour and cognition.

In this single-blinded, randomised, matched-pair trial, we introduce a gluten- and casein-free diet to a group of pre-pubescent children diagnosed with an autism spectrum disorder who also present with an abnormal urinary profile. Following random allocation to a diet or non- diet group, the intervention group will follow the diet for eight months. The non-diet control group will at the same time continue with a normal diet.

At eight months an interim evaluation using standardised autism evaluation methods is used to ascertain whether predetermined thresholds for improvement in any of the assessment measures are met or surpassed by the diet group, compared with initial baseline measures.

If such thresholds are surpassed, the non-diet control group will also start on dietary intervention, with both groups following the diet for a further eight months. In the event such thresholds are not achieved, the intervention group will remain on diet for an additional four months, at which time a secondary interim analysis will be conducted.

After eight plus four months, if the threshold for improvement has been surpassed by the intervention group, the control group will then enter on dietary intervention, and all participants will follow the diet for another twelve months. In the event that no significant improvement has been found in the intervention group at eight plus four months compared to baseline measures, the study will be halted, and both groups will revert back to a normal diet.


Condition Intervention Phase
Autism
Dietary Supplement: Gluten- and casein-free diet
Phase II

MedlinePlus related topics: Autism
Drug Information available for: Casein
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Single Blind (Investigator), Parallel Assignment, Safety/Efficacy Study
Official Title: The ScanBrit Randomised Controlled Study of Gluten- and Casein-Free Dietary Intervention for Children With Autism Spectrum Disorders

Further study details as provided by Center for Autisme, Denmark:

Primary Outcome Measures:
  • Efficacy and safety of a gluten- and caseing-free diet on behavioral variables [ Time Frame: Baseline, 8 months, 12 months, 24 months ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • Changes to pathological urine profiles [ Time Frame: Every 4th month ] [ Designated as safety issue: Yes ]

Enrollment: 80
Study Start Date: April 2006
Estimated Study Completion Date: October 2008
Estimated Primary Completion Date: October 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
A: Experimental
Submitted to dietary intervention
Dietary Supplement: Gluten- and casein-free diet
Gluten- and casein-free diet
B: No Intervention
Control group

  Eligibility

Ages Eligible for Study:   4 Years to 11 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Autism Spectrum Disorder
  • Diagnosis received at Centre for Autism or a psychiatric clinic
  • Abnormal urinary peptide profile

Exclusion Criteria:

  • Medical treatment
  • Epilepsy
  Contacts and Locations
No Contacts or Locations Provided
  More Information

Responsible Party: Center for Autisme ( Director Demetrious Haracopos )
Study ID Numbers: KA 0503g
Study First Received: January 31, 2008
Last Updated: January 31, 2008
ClinicalTrials.gov Identifier: NCT00614198  
Health Authority: Denmark: The Danish National Committee on Biomedical Research Ethics

Keywords provided by Center for Autisme, Denmark:
autism
diet
gluten
casein
intervention
peptide
randomised
controlled

Study placed in the following topic categories:
Developmental Disabilities
Child Development Disorders, Pervasive
Caseins
Mental Disorders
Autistic Disorder
Mental Disorders Diagnosed in Childhood

Additional relevant MeSH terms:
Molecular Mechanisms of Pharmacological Action
Chelating Agents
Pharmacologic Actions

ClinicalTrials.gov processed this record on January 14, 2009